Search

Search results

European Cardiovascular Disease 2006 - Volume 2 Issue 1

… Issue European Cardiovascular Disease 2006 - Volume 2 Issue 1 AER is the … the BHRS Foreword Alberto Cuocolo iD Citation:  European Cardiovascular Disease 2006;2(1):11 Login or register to view … Statistics and Clinical Research Citation:  European Cardiovascular Disease 2006;2(1):12-3 DOI:  …

Type:

Edition

European Cardiovascular Disease 2007 - Volume 3 Issue 2

… Issue European Cardiovascular Disease 2007 - Volume 3 Issue 2 AER is the … official journal of the BHRS Foreword Citation:  European Cardiovascular Disease 2007;3(1):10 DOI:  … as Recommended by the Advisory Panel Citation:  European Cardiovascular Disease 2007;3(2):11 DOI:  …

Type:

Edition

Foreword

… cardiology, from prevention to the final stage of cardiovascular disease, heart failure. I find this highly … or particular field of interest, to take an active role in cardiovascular prevention. Today, public healthcare budgets are almost entirely spent on treating cardiovascular disease, and only minor public resources are …

Type:

Article

European Cardiovascular Disease 2006 - Volume 2 Issue 2

… Issue European Cardiovascular Disease 2006 - Volume 2 Issue 2 AER is the … official journal of the BHRS Foreword Citation:  European Cardiovascular Disease 2006;2(2):10 News Round-up The … Statistics and Clinical Research Citation:  European Cardiovascular Disease 2006;2(2):12-3 DOI:  …

Type:

Edition

European Cardiovascular Disease 2007 - Volume 3 Issue 1

… Issue European Cardiovascular Disease 2007 - Volume 3 Issue 1 AER is the … the BHRS Foreword Sverre E Kjeldsen iD Citation:  European Cardiovascular Disease 2007;3(1):8 DOI:  … as Recommended by the Advisory Panel Citation:  European Cardiovascular Disease 2007;3(1):9 DOI:  …

Type:

Edition

23rd Annual Scientific Meeting of the International Society of Cardiovascular Pharmacotherapy

… Annual Scientific Meeting of the International Society of Cardiovascular Pharmacotherapy Koji Hasegawa iD Register Now … Medical Center, Kyoto, Japan. E: koj@kuhp.kyoto-u.ac.jp Cardiovascular pharmacotherapy has drastically advanced in … the most important first-line therapy for arteriosclerotic cardiovascular disease. The medical treatment of systolic …

Type:

Article

Juan Carlos Kaski

… Juan Carlos Kaski Professor of Cardiovascular Science St George's University of London, … London, UK Biography Juan Carlos Kaski is Professor of Cardiovascular Science at St George's, University of London … Hospital, NHS Trust, London, UK and Director of the Cardiovascular and Cell Sciences Research Institute at SGUL. …

Type:

Author

Assessment of Cardiovascular Risk - The Impact and Future of Non-traditional Cardiovascular Risk Markers

… Text Figures & Tables References Article Assessment of Cardiovascular Risk - The Impact and Future of Non-traditional Cardiovascular Risk Markers Michael Hecht Olsen iD Register …

Type:

Article

Obstructive Sleep Apnoea Syndrome: Continuous Positive Airway Pressure Therapy for Prevention of Cardiovascular Risk

… Positive Airway Pressure Therapy for Prevention of Cardiovascular Risk Maria Pilar Resano-Barrio iD Ramon … Recent evidence suggests that OSA may increase the risk of cardiovascular disease. The relationship between OSA and cardiovascular disease can be explained, at least in part, by …

Type:

Article

European Cardiology Review partners with the International Society of Cardiovascular Pharmacotherapy

… Review partners with the International Society of Cardiovascular Pharmacotherapy Juan Carlos Kaski iD Register … started a partnership with the International Society of Cardiovascular Pharmacotherapy (ISCP), a leading … organisation devoted to medical education in the field of cardiovascular therapy. The mission of the ISCP - an …

Type:

Article